SEMINARS IN CANCER BIOLOGY

SEMINARS IN CANCER BIOLOGY

SEMIN CANCER BIOL
影响因子:15.7
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Academic Press Inc.
发刊时间:1990
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1044-579X

期刊介绍

Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.
《癌症生物学研讨会》是一份评论期刊,致力于让科学家们了解分子肿瘤学领域的发展。每一期都是主题性的,致力于癌症生物学家感兴趣的重要主题,从细胞转化和癌症的潜在遗传和分子原因到潜在治疗的分子基础。每期由一名或多名客座编辑编辑编辑,即该领域国际公认的专家,并包含大约8至12篇关于该主题领域不同方面的权威特邀评论。每期的目的是提供一个协调,可读,生动的审查选定的领域,迅速出版,以确保货币。
年发文量 42
国人发稿量 10.12
国人发文占比 0.24%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周平均15.1周
版面费 US$5150
偏重研究方向 医学-肿瘤学
期刊官网 http://www.journals.elsevier.com/seminars-in-cancer-biology/
投稿链接 https://www.editorialmanager.com/YSCBI

期刊高被引文献

Matrix Metalloproteinases: A challenging paradigm of cancer management.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2017.11.008
CRISPR/Cas9 for cancer research and therapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2018.04.001
The role of SOX family members in solid tumours and metastasis.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.03.004
Akt in cancer: Mediator and more.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.06.002
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.002
SOX2 in development and cancer biology.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.007
Immune checkpoints in the tumor microenvironment.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.06.021
The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.10.013
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.12.007
At a Glance: A History of Autophagy and Cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.11.005
Risk of colorectal cancer in inflammatory bowel diseases.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.001
Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.003
Metabolic flexibility in melanoma: a potential therapeutic target.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.07.016
Role of cell surface proteoglycans in cancer immunotherapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.07.012
Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2018.04.002
SOX4: The Unappreciated Oncogene.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.027
MicroRNA heterogeneity in melanoma progression.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.021
Role of ATP-binding cassette transporters in cancer initiation and progression.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.006
Oncogenic signaling pathways associated with immune evasion and the resistance to immune checkpoint inhibitors in cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.11.011
Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2017.11.002
Monitoring autophagy in cancer: from bench to bedside.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.016
Glyco-Nanoparticles: New drug delivery systems in cancer therapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.12.004
SOX4: Epigenetic Regulation and Role in Tumorigenesis.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.06.022
Ras and exosome signaling.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.02.004
Repurposing Antipsychotics of the Diphenylbutylpiperidine Class for Cancer Therapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.10.007
Pro-survival Autophagy: An Emerging Candidate of Tumor Progression through Maintaining Hallmarks of Cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.020
Autophagy proteins influence endocytosis for MHC restricted antigen presentation.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.03.005
Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.07.013
Implications of nanotechnology for the treatment of cancer: Recent advances.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.028
Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.026
Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.09.018
Exploring the roles of MACIT and Multiplexin collagens in stem cells and cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.033
NANOMEDICINE IN TREATMENT OF BREAST CANCER - A CHALLENGE TO CONVENTIONAL THERAPY.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.12.016
Role of AHR in the control of GBM-associated myeloid cells.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.014
Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.09.025
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.06.011
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.08.029
The Molecular Biology of Pancreatic Neuroendocrine Neoplasms: Challenges and Translational Opportunities.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.09.024
Role of bioactive lipofishins in prevention of inflammation and colon cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2017.11.012
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.12.001
Exploring MYC relevance to cancer biology from the perspective of cell competition.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.05.009
Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges
来源期刊:Seminars in Cancer BiologyDOI:10.1016/J.SEMCANCER.2019.08.030
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.10.015
New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2018.02.008
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.06.004
Transcriptional versus metabolic control of cell fitness during cell competition
来源期刊:Seminars in Cancer BiologyDOI:10.1016/j.semcancer.2019.05.010
Cell Competition in Tumor Evolution and Heterogeneity: Merging Past and Present.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.07.008
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.10.008
What patents tell us about drug repurposing for cancer: A landscape analysis.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.09.010
Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
来源期刊:Seminars in cancer biologyDOI:10.1016/j.semcancer.2019.12.009

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
95.24%23.21%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
ONCOLOGY 肿瘤学
2区
2023年12月升级版
医学1区
ONCOLOGY 肿瘤学
2区
2022年12月旧的升级版
医学1区
ONCOLOGY 肿瘤学
2区